Will be a TO I reckon. Why would the pharma want to share the product with their peers? With their deep pocket, buying out noxopharm will be loose change.
Ann: Noxopharm IONIC Immuno-Oncology Trial Commences, page-6
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.04M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 67557 | 6.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.0¢ | 1310 | 1 |
View Market Depth
| Last trade - 10.06am 01/08/2024 (20 minute delay) ? |
| NOX (ASX) Chart |
Day chart unavailable